Environmental, social and governance (ESG) imperatives impact every aspect of the work of clinical trial operations.
The world is moving toward a greener economy – meaning that investors, financial institutions and the general public all want to see evidence of ESG activities associated with the funding they make available to organizations. A business’s reputation is increasingly defined not just by how effective its products are, its customer service, but also by how invested it is around ESG.
In this webinar you will:
- UNDERSTAND how and why life sciences companies are being affected by environmental, social and governance (ESG) imperatives today
- EXAMINE how clinical operations leaders should plan for their organization’s ESG priorities
- CREATE a plan to move your organization forward on ESG priorities
